Literature DB >> 30784907

Sinomenine inhibits proliferation, migration, invasion and promotes apoptosis of prostate cancer cells by regulation of miR-23a.

Feng Xu1, Qi Li1, Zhiyu Wang1, Xiangming Cao2.   

Abstract

Background Prostate cancer is an extremely common disease in males, and the mortality of prostate cancer has been rising year by year. Sinomenine has been reported to exhibit anti-tumor effect on various cancers, but the function of Sinomenine in prostate cancer remains unclear. The study aimed to explore the effect of Sinomenine on proliferation, apoptosis, migration and invasion in prostate cancer cells. Methods PC3 cells were stimulated by different concentrations of Sinomenine, then cell proliferation, migration, invasion and apoptosis were examined by CCK-8, BrdU, Transwell and flow cytometry, respectively. Subsequently, miR-23a mimic and miR-23a inhibitor were transfected into PC3 and LNCaP cells, cell proliferation, apoptosis, migration and invasion were reassessed in these transfected cells. The related factors of cell cycle, apoptosis, metastasis and PI3K/AKT and JAK/STAT signal pathways were measured by western blot. Results Sinomenine significantly suppressed cell proliferation, promoted apoptosis and inhibited migration and invasion, as well as down-regulated Cyclin D1, CDK4, Bcl-2, MMP-2, MMP-9, Vimentin protein levels and up-regulated p16 and Bax protein levels in PC3 cells. Additionally, Sinomenine decreased the expression level of miR-23a, and overexpression of miR-23a reversed the effects of Sinomenine on cell proliferation, apoptosis, migration and invasion in PC3 and LNCaP cells. Further, Sinomenine inactivated PI3K/AKT and JAK/STAT signal pathways by regulation of miR-23a. Conclusions The data suggested that Sinomenine could suppress cell proliferation, migration, invasion, and promote apoptosis of prostate cancer cells through regulation of miR-23a. These findings might provide a possible strategy for the clinical treatment of prostate cancer.
Copyright © 2019 Elsevier Masson SAS. All rights reserved.

Entities:  

Keywords:  JAK/STAT; MicroRNA-23a; PI3K/AKT; Prostate cancer; Sinomenine

Mesh:

Substances:

Year:  2019        PMID: 30784907     DOI: 10.1016/j.biopha.2019.01.053

Source DB:  PubMed          Journal:  Biomed Pharmacother        ISSN: 0753-3322            Impact factor:   6.529


  20 in total

Review 1.  MicroRNA mediated therapeutic effects of natural agents in prostate cancer.

Authors:  Km Anjaly; A B Tiku
Journal:  Mol Biol Rep       Date:  2021-07-24       Impact factor: 2.316

2.  Icariin inhibits the malignant progression of lung cancer by affecting the PI3K/Akt pathway through the miR‑205‑5p/PTEN axis.

Authors:  Fengjie Zhu; Zhe Ren
Journal:  Oncol Rep       Date:  2022-05-06       Impact factor: 4.136

3.  Sinomenine Inhibits Migration and Invasion of Human Lung Cancer Cell through Downregulating Expression of miR-21 and MMPs.

Authors:  Kun-Hung Shen; Jui-Hsiang Hung; Yi-Ching Liao; Shu-Ting Tsai; Ming-Jiuan Wu; Pin-Shern Chen
Journal:  Int J Mol Sci       Date:  2020-04-27       Impact factor: 5.923

4.  Sinomenine Inhibits Non-Small Cell Lung Cancer via Downregulation of Hexokinases II-Mediated Aerobic Glycolysis.

Authors:  Wenbin Liu; Xinfang Yu; Li Zhou; Jigang Li; Ming Li; Wei Li; Feng Gao
Journal:  Onco Targets Ther       Date:  2020-04-16       Impact factor: 4.147

5.  Sinomenine sensitizes human gastric cancer cells to cisplatin through negative regulation of PI3K/AKT/Wnt signaling pathway.

Authors:  Ying Liu; Changqing Liu; Ting Tan; Shang Li; Shunyu Tang; Xingyin Chen
Journal:  Anticancer Drugs       Date:  2019-11       Impact factor: 2.248

Review 6.  Two Worlds Colliding: The Interplay Between Natural Compounds and Non-Coding Transcripts in Cancer Therapy.

Authors:  Alexandru A Sabo; Maria Dudau; George L Constantin; Tudor C Pop; Christoph-M Geilfus; Alessio Naccarati; Mihnea P Dragomir
Journal:  Front Pharmacol       Date:  2021-07-06       Impact factor: 5.810

7.  Sinomenine Suppresses Development of Hepatocellular Carcinoma Cells via Inhibiting MARCH1 and AMPK/STAT3 Signaling Pathway.

Authors:  Wei Yang; Qihua Feng; Minjing Li; Jiaqi Su; Peiyuan Wang; Xu Wang; Yancun Yin; Xia Wang; Mingdong Zhao
Journal:  Front Mol Biosci       Date:  2021-06-10

8.  Discovery of chemical markers for improving the quality and safety control of Sinomenium acutum stem by the simultaneous determination of multiple alkaloids using UHPLC-QQQ-MS/MS.

Authors:  Yu-Feng Huang; Fan He; Can-Jian Wang; Ying Xie; Yan-Yu Zhang; Zhen Sang; Ping Qiu; Pei Luo; Sheng-Yuan Xiao; Jing Li; Fei-Ci Wu; Liang Liu; Hua Zhou
Journal:  Sci Rep       Date:  2020-08-25       Impact factor: 4.379

9.  Vimentin as a target for the treatment of COVID-19.

Authors:  Zhenlin Li; Denise Paulin; Patrick Lacolley; Dario Coletti; Onnik Agbulut
Journal:  BMJ Open Respir Res       Date:  2020-09

10.  ZIC2 upregulates lncRNA SNHG12 expression to promote endometrial cancer cell proliferation and migration by activating the Notch signaling pathway.

Authors:  Pengyu Cai; Gaijuan Li; Mingxiu Wu; Bin Zhang; Hong Bai
Journal:  Mol Med Rep       Date:  2021-07-19       Impact factor: 2.952

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.